COVID-19 Respiratory Infection: Clinical Trials

110 trials for COVID-19 Respiratory Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

54 completed, 40 unknown, 4 recruiting, 4 terminated. 27 Not applicable, 16 Phase 3, 15 Phase 2, 10 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 15, Unknown 8, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 316Completed 7, Unknown 7, Terminated 1, Withdrawn 1
Phase 215Unknown 7, Completed 5, Withdrawn 2, Suspended 1
Phase 110Unknown 6, Completed 3, Terminated 1
Phase 43Completed 1, Terminated 1, Unknown 1
Early Phase 11Suspended 1

Follow COVID-19 Respiratory Infection: new trials by email Literature Review of COVID-19 Respiratory Infection trials Research Report on COVID-19 Respiratory Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections
RD-X19, RD-X19 Sham - COVID-19 Respiratory Infection, Influenza
Not applicableRecruitingDavid Moss1302026-10-012026-10-26
Pancoronavirus Vaccine Study in Healthy Adults
CoV-RBD-scNP-001 and 3M-052-AF - COVID-19 Respiratory Infection, SARS CoV 2 Infection
Phase 1TerminatedDuke University42025-08-012026-10-19
Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients
IMMUNO19 - COVID-19 Respiratory Infection, COVID-19
Not applicableUnknownBiodex S.A2802024-09-152024-06-13
NAC for Attenuation of COVID-19 Symptomatology
N-acetylcysteine, Placebo - Covid19, COVID-19 Pneumonia
Phase 2UnknownCambridge Health Alliance2002024-03-312023-08-07
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
A&M Breathalyzer PROTECT Kiosk - COVID-19, SARS CoV 2 Virus
RecruitingThe Geneva Foundation1002023-12-272025-12-10
Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection
COVID-19 Respiratory Infection
UnknownUniversity Hospital, Strasbourg, France752023-09-042024-07-08
Posture and Pain Measurements in Post-COVID-19
Physical evaluations of post-COVID-19 individuals - COVID-19 Respiratory Infection
CompletedIzmir Democracy University412023-09-012025-06-05
Infection Watch Study
COVID-19 Respiratory Infection, Respiratory Syncytial Virus Infections
CompletedDuke University100342023-06-282024-07-03
Pain, Physical Activity, Posture and Quality of Life in Post-COVID-19 Individuals With Idiopathic Scoliosis
Physical Evaluations of post-COVID-19 individuals, Physical evaluations of non-post-COVID-19 individuals - COVID-19 Respiratory Infection, Idiopathic Scoliosis
CompletedIzmir Democracy University412023-06-162025-05-25
Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
Physical Evaluations of post-COVID-19 individuals, Physical Evaluations of non-post-COVID-19 individuals - COVID-19 Respiratory Infection, Parkinson Disease
CompletedIzmir Democracy University322023-05-132025-05-18
Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants
GST-HG171/ritonavir, ritonavir - COVID-19 Respiratory Infection
Phase 1UnknownFujian Akeylink Biotechnology Co., Ltd.182023-05-042023-10-16
COVID-19 Vaccination Detoxification in LDL-C
Atorvastatin Calcium Tablets - COVID-19 Stress Syndrome, COVID-19 Vaccine Adverse Reaction
Phase 1UnknownYang I. Pachankis12023-05-012023-05-06
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
Azvudine, Placebo - COVID-19 Respiratory Infection
Phase 2 / Phase 3UnknownPeking Union Medical College Hospital10962023-04-192024-11-25
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
Labcorp COVID-19+Flu+RSV Test Home Collection Kit - COVID-19 Respiratory Infection, Influenza A
CompletedSequenom, Inc.16002023-04-172025-06-25
A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
DNA vaccine OC-007, Placebo - COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction
Phase 1CompletedMatti Sällberg162023-02-082024-03-27
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
COVID-19 Respiratory Infection
CompletedFoundation for Innovative New Diagnostics, Switzerland6002023-01-302023-10-05
Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response
Vitamin-D - COVID-19 Respiratory Infection
Phase 3CompletedSulaimani Polytechnic University5002022-12-052023-05-12
Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19
VL-PX10 and VL-P22 plus standard care, Placebo - Pulmonary Fibrosis, COVID-19 Respiratory Infection
Phase 2SuspendedVitti Labs, LLC202022-11-302024-09-19
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
Venovenous ECMO - Mechanical Ventilation Complication, Hypoxemia
Not applicableRecruitingAustralian and New Zealand Intensive Care Research Centre1402022-11-282024-08-09
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
Azvudine - COVID-19 Respiratory Infection
UnknownQianfoshan Hospital5002022-11-222023-10-03

Showing 20 of 110. Sign in to see all of them.

Narrower conditions

COVID-19 (48)  ·  Coronavirus Infections (8)  ·  Post-Acute COVID-19 Syndrome (6)  ·  Influenza, Human (5)  ·  Respiratory Distress Syndrome (5)  ·  Pain (4)  ·  Motor Activity (3)  ·  Pneumonia (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Anxiety Disorders (2)  ·  Cough (2)  ·  Critical Illness (2)  ·  Cytokine Release Syndrome (2)  ·  Disease (2)

Broader conditions

Infections (66)  ·  Respiratory Tract Diseases (66)  ·  Lung Diseases (61)  ·  RNA Virus Infections (60)  ·  Virus Diseases (60)  ·  Respiratory Tract Infections (58)  ·  Coronaviridae Infections (55)  ·  Nidovirales Infections (55)  ·  Pneumonia (54)  ·  Pneumonia, Viral (52)  ·  Coronavirus Infections (47)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Pathologic Processes (17)  ·  Signs and Symptoms (11)  ·  Disease Attributes (10)

Interventions

Control Groups (4)  ·  Standard of Care (3)  ·  Vitamin D (3)  ·  Acetaminophen (2)  ·  COVID-19 Vaccines (2)  ·  Echocardiography (2)  ·  Prone Position (2)  ·  azvudine (2)  ·  Acetylcysteine (1)  ·  Albuterol (1)  ·  Antibodies, Monoclonal (1)  ·  Ascorbic Acid (1)  ·  Asian ginseng (1)  ·  Aspirin (1)  ·  Atorvastatin (1)

Sponsors

Izmir Democracy University (3)  ·  SPP Pharmaclon Ltd. (3)  ·  Abant Izzet Baysal University (2)  ·  Assiut University (2)  ·  Bharat Biotech International Limited (2)  ·  Duke University (2)  ·  Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (2)  ·  Federal University of Paraíba (2)  ·  Foundation for Innovative New Diagnostics, Switzerland (2)  ·  University of Pernambuco (2)  ·  University of Turin, Italy (2)  ·  A. Vogel AG (1)  ·  Abbott Rapid Diagnostics Jena GmbH (1)  ·  Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran (1)  ·  Aga Khan University (1)

Countries

United States (17)  ·  Turkey (Türkiye) (8)  ·  India (7)  ·  Italy (7)  ·  Brazil (6)  ·  Egypt (6)  ·  Russia (6)  ·  China (5)  ·  Spain (5)  ·  Canada (4)  ·  France (4)  ·  Germany (3)  ·  Poland (3)  ·  Australia (2)  ·  United Kingdom (2)

Top investigators

Anatoly I Saulin, Master (3)  ·  Agnieszka Jankowska, doctor (1)  ·  Aidan Burrell, MBBS (1)  ·  Ajay Gupta, MD (1)  ·  Alexander Phan, MD (1)  ·  Alexander T Limkakeng, MD (1)  ·  Amira Badran, PhD (1)  ·  Andrzej Stepulak, Prof (1)  ·  Antoni Torres, MD (1)  ·  Anuradha Rajamanickam, PhD (1)  ·  Babatunde L Salako, MBBS, FRCP (1)

Results publications

PMID 11018445, PMID 11801425, PMID 12186831, PMID 12472328, PMID 16139521, PMID 17311621, PMID 18292919, PMID 18511703, PMID 1878176, PMID 18952011, PMID 19179052, PMID 19406254, PMID 19423360, PMID 19533636, PMID 19691668, PMID 20518086, PMID 21821430, PMID 22254114, PMID 22895087, PMID 23011532, PMID 23188495, PMID 23980134, PMID 24012996, PMID 24035013, PMID 24717726, PMID 24744386, PMID 25208082, PMID 25437305, PMID 25711114, PMID 25972965, PMID 26112621, PMID 26165624, PMID 26211979, PMID 26457181, PMID 27547201, PMID 27826541, PMID 27894277, PMID 27993601, PMID 28101565, PMID 28820608, PMID 28923425, PMID 28986861, PMID 29128354, PMID 30080234, PMID 30224027, PMID 30658230, PMID 31101987, PMID 31475544, PMID 31986261, PMID 31986264

NIH funding

R01HL159055 (1), U01DC019579 (1), U24MD016258 (1)